TYK Medicines, Inc (HKG: 2410)
Hong Kong
· Delayed Price · Currency is HKD
45.00
-3.00 (-6.25%)
Jan 6, 2025, 4:08 PM HKT
TYK Medicines Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -427.94 | -382.43 | -310.99 |
| Depreciation & Amortization | 28.52 | 27.64 | 16.33 |
| Other Amortization | 20.64 | 8 | - |
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0.04 |
| Loss (Gain) From Sale of Investments | -0.01 | 0.73 | -0.34 |
| Stock-Based Compensation | 10.92 | 3.89 | - |
| Other Operating Activities | 101.96 | 90.17 | 76.57 |
| Change in Accounts Receivable | 1.15 | -11.27 | -19.6 |
| Change in Accounts Payable | 30.97 | 62.32 | -4.89 |
| Change in Other Net Operating Assets | - | - | 22.83 |
| Operating Cash Flow | -233.78 | -200.94 | -220.05 |
| Capital Expenditures | -44.52 | -76.38 | -58.97 |
| Sale of Property, Plant & Equipment | 4.83 | 0.07 | 0 |
| Sale (Purchase) of Intangibles | - | -0.88 | -29.21 |
| Investment in Securities | -33.01 | 149.03 | -64.15 |
| Other Investing Activities | 1.17 | 1.17 | -5.84 |
| Investing Cash Flow | -71.54 | 73.01 | -158.17 |
| Long-Term Debt Repaid | - | -16.48 | -1.61 |
| Net Debt Issued (Repaid) | 22.88 | -16.48 | -1.61 |
| Issuance of Common Stock | 235 | 185 | 325 |
| Other Financing Activities | 29.83 | 55.47 | 27.75 |
| Financing Cash Flow | 287.71 | 224 | 351.14 |
| Foreign Exchange Rate Adjustments | -0.16 | 0.01 | - |
| Net Cash Flow | -17.77 | 96.07 | -27.08 |
| Free Cash Flow | -278.3 | -277.32 | -279.02 |
| Free Cash Flow Margin | - | - | -630.67% |
| Free Cash Flow Per Share | -0.91 | -0.96 | -1.00 |
| Levered Free Cash Flow | - | 94.34 | - |
| Unlevered Free Cash Flow | - | 99.8 | - |
| Change in Net Working Capital | - | -330.37 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.